- Location
1
result for "
HCMV
"-
Merck Has Signed a Licensing Agreement with Aicuris for Hcmv Investigational Medicines
Nov 28, 2012Merck has signed a licensing agreement with AiCuris for the worldwide development and commercialisation rights of candidates in AiCuris' Human Cytomegalovirus (HCMV) portfolio. The HCMV portfolio includes letermovir (AIC246), an oral, ...
